Adipose tissue and metabolic alterations: Regional differences in fat cell size and number matter, but differently: A cross-sectional study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages E1870-E1876

  Rydén, Mikael ^a   Andersson, Daniel P ^a   Bergström, Ingrid B ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; BODY MASS; CELL METABOLISM; CELL SIZE; CELL VOLUME; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; STOMACH BYPASS; TISSUE METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE; ADOLESCENT; BLOOD; GLUCOSE CLAMP TECHNIQUE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; OMENTUM; PATHOLOGY; PHYSIOLOGY; PREOPERATIVE PERIOD; SUBCUTANEOUS FAT; YOUNG ADULT;

ADIPOCYTES; ADOLESCENT; ADULT; CELL SIZE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, MORBID; OMENTUM; PREOPERATIVE PERIOD; SUBCUTANEOUS FAT; TRIGLYCERIDES; YOUNG ADULT;

EID: 84907655202     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1526     Document Type: Article

References (40)

1. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med. 2005;12:75-80.
2. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.
3. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704.
4. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus nonsurgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
5. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric by pass. Obes Surg. 2013;23:93-102.
6. Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care. 2013;36(Suppl 2):S287-S291.
7. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549-2557.
8. Mohammed BS, Cohen S, Reeds D, Young VL, Klein S. Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity (Silver Spring). 2008;16:2648-2651.
9. Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139:448-455.
10. Dillard TH, Purnell JQ, Smith MD, et al. Omentectomy added to Roux-en-Y gastric by pass surgery: a randomized, controlled trial. Surg Obes Relat Dis. 2013;9:269-275.
11. Herrera MF, Pantoja JP, Velázquez-Fernández D, et al. Potential additional effect of omentectomy on metabolic syndrome, acutephase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric by pass: a randomized trial. Diabetes Care. 2010;33:1413-1418.
12. Andersson DP, Thorell A, Löfgren P, et al. Omentectomy in addition to gastric by pass surgery and influence on insulin sensitivity: a randomized double blind controlled trial [published online January 12, 2014]. Clin Nutr. doi:10.1016/j.clnu.2014.01.004.
13. Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab. 1976;5:299-311.
14. Hoffstedt J, Arner E, Wahrenberg H, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia. 2010;53:2496-2503.
15. Veilleux A, Caron-Jobin M, Noël S, Laberge PY, Tchernof A. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes. 2011;60:1504-1511.
16. Salans LB, Knittle JL, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest. 1968;47:153-165.
17. Lundgren M, Svensson M, Lindmark S, Renström F, Ruge T, Eriksson JW. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia. 2007;50:625-633.
18. Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes. 2010;59:105-109.
19. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000;43:1498-1506.
20. Lönn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. Faseb J. 2010;24:326-331.
21. Kaul S, Rothney MP, Peters DM, et al. Dual-energy x-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring). 2012;20:1313-1318.
22. Arner P, Andersson DP, Thörne A, et al. Variations in the size of the major omentum are primarily determined by fat cell number. J Clin Endocrinol Metab. 2013;98:E897-E901.
23. Tchoukalova YD, Harteneck DA, Karwoski RA, Tarara J, Jensen MD. A quick, reliable, and automated method for fat cell sizing. J Lipid Res. 2003;44:1795-1801.
24. Goldrick RB. Morphological changes in the adipocyte during fat deposition and mobilization. Am J Physiol. 1967;212:777-782.
25. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res. 1968;9:110-119.
26. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150-1162.
27. Rydén M, Arner P. Tumour necrosis factor-alpha in human adipose tissue-from signalling mechanisms to clinical implications. J Intern Med. 2007;262:431-438.
28. Arner E, Ryden M, Arner P. Tumor necrosis factor alpha and regulation of adipose tissue. N Engl J Med. 2010;362:1151-1153.
29. Wree A, Kahraman A, Gerken G, Canbay A. Obesity affects the liver - the link between adipocytes and hepatocytes. Digestion. 2011;83:124-133.
30. Wree A, Mayer A, Westphal S, et al. Adipokine expression in brown and white adipocytes in response to hypoxia. J Endocrinol Invest. 2012;35:522-527.
31. Gao H, Mejhert N, Fretz JA, et al. Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab. 2014;19(6):981-992.
32. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta. 2010;1801:338-349.
33. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783-787.
34. Park YW, Heymsfield SB, Gallagher D. Are dual-energy x-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord. 2002;26:978-983.
35. Rothney MP, Xia Y, Wacker WK, et al. Precision of a new tool to measure visceral adipose tissue (VAT) using dual-energy x-ray absorptiometry (DXA). Obesity (Silver Spring). 2013;21:E134-E136.
36. Ahima RS, Lazar MA. Physiology. The health risk of obesity-better metrics imperative. Science. 2013;341:856-858.
37. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010;21:38-43.
38. Miles JM, Jensen MD. Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care. 2005;28:2326-2328.
39. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005;28:2322-2325.
40. Smith U, Sjöström L, Björnstorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res. 1972;13:822-824.